| Application of plasmapheresis for Covid‐19 patients A Turgutkaya, İ Yavaşoğlu, Z Bolaman Therapeutic Apheresis and Dialysis 25 (2), 248, 2020 | 33 | 2020 |
| The relationship between red cell distribution width and prognostic scores in myelodysplastic syndrome A Turgutkaya, N Akın, G Sargın, Z Bolaman, İ Yavaşoğlu Hematology, Transfusion and Cell Therapy 44 (3), 332-335, 2022 | 12 | 2022 |
| COVID-19-associated Evans syndrome: A case report and review of the literature A Turgutkaya, AZ Bolaman, İ Yavaşoğlu Transfusion and Apheresis Science 61 (3), 103339, 2022 | 7 | 2022 |
| The association between Hba1c and arterial stiffness among non-diabetic patients with chronic kidney disease A Turgutkaya, G Aşçı Jornal Vascular Brasileiro 20, e20200245, 2021 | 5 | 2021 |
| Yavaso glu _I, Bolaman Z. Application of plasmapheresis for Covid-19 patients A Turgutkaya Ther Apher Dial 25 (2), 248-9, 2021 | 5 | 2021 |
| Pharmacological dose ascorbic acid administration in relapsed refractory multiple myeloma patients AZ Bolaman, A Turgutkaya, HE Küçükdiler, C Selim, İ Yavaşoğlu Leukemia Research Reports 16, 100281, 2021 | 4 | 2021 |
| The evaluation of gene mutation profiles by next‐generation sequencing in diffuse large B‐cell lymphoma A Özçalımlı, İH Erdoğdu, A Turgutkaya, İ Yavaşoğlu, FK Döger, ... International Journal of Laboratory Hematology 45 (3), 310-316, 2023 | 3 | 2023 |
| RETRACTED: Factors Affecting Time to Engraftment During Autologous Stem Cell Transplantation in Patients With Multiple Myeloma AZ Bolaman, A Turgutkaya, İ Yavaşoğlu Plasmatology 15, 26348535211042015, 2021 | 3 | 2021 |
| Pregnancy and immune thrombocytopenia: New trends İ Yavaşoğlu, A Turgutkaya Journal of the Turkish German Gynecological Association 21 (2), 136, 2020 | 3 | 2020 |
| Can plasmapheresis be useful in the treatment of patients with Covid-19 AZ Bolaman, A Turgutkaya, İ Yavaşoğlu Asian Hematol Res J, 1-4, 2020 | 3 | 2020 |
| Deferasirox-Induced Hyperammonemia in an Adult Patient After Allogeneic Stem Cell Transplantation A Turgutkaya, AZ Bolaman, İ Yavaşoğlu Annals of Pharmacotherapy 56 (1), 104-105, 2022 | 2 | 2022 |
| Multiple myeloma and frequency of synchronous and second primary malignancies A Turgutkaya, İ Yavaşoğlu, T Şahin, G Sargın, AZ Bolaman Journal of Hematopathology 14 (3), 197-203, 2021 | 2 | 2021 |
| Acquired ichthyosis as a messenger to gastric diffuse large B-cell lymphoma İ Yavaşoğlu, A Turgutkaya, C Tataroğlu, AZ Bolaman Anais Brasileiros de Dermatologia 99 (6), 956-957, 2024 | 1 | 2024 |
| Investigation of demographic features, performance, comorbidity status and mortality causes among multiple myeloma patients: real-life data T Şahin, A Turgutkaya, G Kadıköylü, AZ Bolaman, İ Yavaşoğlu Expert Review of Hematology 14 (12), 1147-1153, 2021 | 1 | 2021 |
| Experience of Daratumumab in Six Patients With Multiple Myeloma and Kidney Failure A Turgutkaya, AZ Bolaman, İ Yavaşoğlu Plasmatology 15, 26348535211042012, 2021 | 1 | 2021 |
| Original versus generic lenalidomide in patients with relapsed/refractory multiple myeloma: comparison of efficacy and adverse events AZ Bolaman, A Turgutkaya, B Sahip, C Selim, HE Küçükdiler, Ş Ertop, ... Turkish Journal of Hematology 38 (1), 41, 2021 | 1 | 2021 |
| Acute Myeloblastic Leukemia with Multiple Extramedullary Relapses A Turgutkaya, İ Yavaşoğlu, Z Bolaman مجله ی خون و سرطان ایران 13 (1), 32-34, 2021 | 1 | 2021 |
| Ruxolitinib induced leukocytoclastic vasculitis A Turgutkaya, İ Yavaşoğlu Medicina Clinica 157 (10), 501-501, 2020 | 1 | 2020 |
| The dilemma between autoimmune trombocytopenia and celiac disease A Turgutkaya, İ Yavaşoğlu Indian Journal of Hematology and Blood Transfusion 36, 590-591, 2020 | 1 | 2020 |
| Daratumumab-associated varicella-zoster virus meningoencephalitis in relapsed refractory multiple myeloma A Turgutkaya, AZ Bolaman, İ Yavaşoğlu Acta Medica 55 (4), 292-294, 2024 | | 2024 |
